Developing Innovative Therapeutics for Ocular Diseases Global leading candidate in Phase 2b for the treatment of adenoviral conjunctivitis. Research & Development Enhancing Lives Through Better Vision Okogen, founded in 2015, is a clinical stage ophthalmic specialty biotechnology company. We are exclusively focused on developing the leading treatment of adenoviral conjunctivitis. With acute conjunctivitis representing 1% […]
Location: United States, California, San Diego
Member count: 1-10
Founded date: 2015
Investors 1
| Date | Name | Website |
| - | Brandon Ca... | brandoncap... |